Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Hankerchiefon Nov 01, 2018 1:49pm
40 Views
Post# 28909312

RE:RE:RE:RE:Dr. Kamat Weighs in on Phase 2

RE:RE:RE:RE:Dr. Kamat Weighs in on Phase 2OK.  I understand and it makes sense.  But what's in it for them (the MSAB)?  What do they have to gain?  Are they invested?  It seems not.  We need some movers and shakers IMO.  I know, I know, easier said than done  There is no way I could do what they are doing.  Then again I don't have their brains and passion.


Eoganacht wrote: Hankerchief - this is also from the May 30 press release:

"The MSAB is comprised of world-renowned experts in bladder cancer and have been retained by the Company to provide advice and strategic guidance on the research, development and commercialization of the TLD-1433-based PDT technology in the treatment of patients inflicted with NMIBC."

The MSAB exists to advise the company not the public.

Hankerchief wrote: That's nice.  But I wonder why he is an MASB member?  He has awesome credentials but what's in it for him?  Is he invested?  The tech is great.  Would love to see some progress here. 
P.S.  Ok, I'm whining sort of, but not really.....and I'm not a basher.  And I'm not little (6'2", 220#).


Dr. Kamat is our independent MSAB member for the NMIBC indication.
Read more at https://www.stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?postid=28908980#EOlcs4kRjVJYw5qK.99




Bullboard Posts